Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2011 3
2012 2
2013 1
2014 1
2015 1
2016 1
2017 1
2018 2
2019 2
2020 2
Text availability
Article attribute
Article type
Publication date

Search Results

15 results
Results by year
Filters applied: . Clear all
Page 1
Endocannabinoid System: A Multi-Facet Therapeutic Target.
Kaur R, Ambwani SR, Singh S. Kaur R, et al. Curr Clin Pharmacol. 2016;11(2):110-7. doi: 10.2174/1574884711666160418105339. Curr Clin Pharmacol. 2016. PMID: 27086601 Review.
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, cancer, obesity, metabolic syndrome related diseases, Parkinson's disease, Huntington's disease, Alzheimer's disease and Tour …
Several diseases like emesis, pain, inflammation, multiple sclerosis, anorexia, epilepsy, glaucoma, schizophrenia, cardiovascular disorders, …
Anorexia and the Cancer Patient.
Johannes CM, Musser ML. Johannes CM, et al. Vet Clin North Am Small Anim Pract. 2019 Sep;49(5):837-854. doi: 10.1016/j.cvsm.2019.04.008. Epub 2019 Jun 6. Vet Clin North Am Small Anim Pract. 2019. PMID: 31176457 Review.
Cancer-related anorexia/cachexia syndrome is a metabolic, paraneoplastic syndrome characterized by decreased food intake, involuntary weight loss, and loss of fat and muscle. ...
Cancer-related anorexia/cachexia syndrome is a metabolic, paraneoplastic syndrome characterized by decreased food intak …
[The potential use of cannabidiol in the therapy of metabolic syndrome].
Kleiner D, Ditrói K. Kleiner D, et al. Orv Hetil. 2012 Apr 1;153(13):499-504. doi: 10.1556/OH.2012.29308. Orv Hetil. 2012. PMID: 22430005 Review. Hungarian.
Cannabidiol has an immunomodulating effect, as well, that helps lessen the progression of atherosclerosis induced by high glucose level. It may also be effective in fighting ischaemic diseases, the most harmful complications of metabolic syndrome. However, it
Cannabidiol has an immunomodulating effect, as well, that helps lessen the progression of atherosclerosis induced by high glucose lev
Cannabidiol as an emergent therapeutic strategy for lessening the impact of inflammation on oxidative stress.
Booz GW. Booz GW. Free Radic Biol Med. 2011 Sep 1;51(5):1054-61. doi: 10.1016/j.freeradbiomed.2011.01.007. Epub 2011 Jan 14. Free Radic Biol Med. 2011. PMID: 21238581 Free PMC article. Review.
In this context, the related nonpsychotropic cannabinoid cannabidiol, which may interact with the endocannabinoid system but has actions that are distinct, offers promise as a prototype for anti-inflammatory drug development. ...These include rheumatoid arthritis, types 1 …
In this context, the related nonpsychotropic cannabinoid cannabidiol, which may interact with the endocannabinoid system but has acti …
Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis.
Silvestri C, Paris D, Martella A, Melck D, Guadagnino I, Cawthorne M, Motta A, Di Marzo V. Silvestri C, et al. J Hepatol. 2015 Jun;62(6):1382-90. doi: 10.1016/j.jhep.2015.01.001. Epub 2015 Jan 13. J Hepatol. 2015. PMID: 25595882
BACKGROUND & AIMS: Obesity and associated metabolic syndrome have quickly become a pandemic and a major detriment to global human health. ...CONCLUSIONS: Our results suggest that THCV and CBD might be used as new therapeutic agents for the pharmacological treatm …
BACKGROUND & AIMS: Obesity and associated metabolic syndrome have quickly become a pandemic and a major detriment to globa …
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia: Implications for Pharmacological Intervention.
Leweke FM, Mueller JK, Lange B, Fritze S, Topor CE, Koethe D, Rohleder C. Leweke FM, et al. CNS Drugs. 2018 Jul;32(7):605-619. doi: 10.1007/s40263-018-0539-z. CNS Drugs. 2018. PMID: 30022465 Review.
Although multiple pharmacological treatment options exist, e.g. first- or second-generation antipsychotics, these therapeutics often cause disturbing side effects, such as extrapyramidal symptoms, prolactin increase, sexual dysfunction and/or metabolic syndrome. ... …
Although multiple pharmacological treatment options exist, e.g. first- or second-generation antipsychotics, these therapeutics often cause d …
Translating Endocannabinoid Biology into Clinical Practice: Cannabidiol for Stroke Prevention.
Scharf EL. Scharf EL. Cannabis Cannabinoid Res. 2017 Oct 1;2(1):259-264. doi: 10.1089/can.2017.0033. eCollection 2017. Cannabis Cannabinoid Res. 2017. PMID: 29098188 Free PMC article. Review.
Furthermore, cannabidiol (CBD), a nonpsychoactive constituent of Cannabis, is an immediate therapeutic candidate both for potentiating endocannabinoid signaling and for acting at multiple pharmacological targets. Conclusion: This speculative synthesis explores the current …
Furthermore, cannabidiol (CBD), a nonpsychoactive constituent of Cannabis, is an immediate therapeutic candidate both for potentiatin …
Cannabis and Δ9-tetrahydrocannabinol (THC) for weight loss?
Le Foll B, Trigo JM, Sharkey KA, Le Strat Y. Le Foll B, et al. Med Hypotheses. 2013 May;80(5):564-7. doi: 10.1016/j.mehy.2013.01.019. Epub 2013 Feb 11. Med Hypotheses. 2013. PMID: 23410498
This phenomenon led to an exploration of the role of the endocannabinoid system in the regulation of obesity and associated metabolic syndrome. ...We therefore propose the seemingly paradoxical hypothesis that THC or a THC/cannabidiol combination drug may pro …
This phenomenon led to an exploration of the role of the endocannabinoid system in the regulation of obesity and associated metabolic
Epilepsy and cannabidiol: a guide to treatment.
Arzimanoglou A, Brandl U, Cross JH, Gil-Nagel A, Lagae L, Landmark CJ, Specchio N, Nabbout R, Thiele EA, Gubbay O, The Cannabinoids International Experts Panel; Collaborators. Arzimanoglou A, et al. Epileptic Disord. 2020 Feb 1;22(1):1-14. doi: 10.1684/epd.2020.1141. Epileptic Disord. 2020. PMID: 32096470
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is reflected in recent changes in legislation in some countries. Although there has been much speculation about the therapeutic value of cannabi …
The growing interest in cannabidiol (CBD), specifically a pure form of CBD, as a treatment for epilepsy, among other conditions, is r …
VCE-004.8, A Multitarget Cannabinoquinone, Attenuates Adipogenesis and Prevents Diet-Induced Obesity.
Palomares B, Ruiz-Pino F, Navarrete C, Velasco I, Sánchez-Garrido MA, Jimenez-Jimenez C, Pavicic C, Vazquez MJ, Appendino G, Bellido ML, Calzado MA, Tena-Sempere M, Muñoz E. Palomares B, et al. Sci Rep. 2018 Oct 31;8(1):16092. doi: 10.1038/s41598-018-34259-0. Sci Rep. 2018. PMID: 30382123 Free PMC article.
Over the past few years, the endocannabinoid system (ECs) has emerged as a crucial player for the regulation of food intake and energy metabolism, and its pharmacological manipulation represents a novel strategy for the management of metabolic diseases. The discovery that …
Over the past few years, the endocannabinoid system (ECs) has emerged as a crucial player for the regulation of food intake and energy metab …
15 results
Jump to page
Feedback